TRVN:OTCMKTS
Trevena Inc
USD 0.012
0.00%
(0.00) 1H
6 Okt, 10:01:51 PG GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk TRVN...
Permodalan Pasaran
10.37K
Purata volum
182.00
Volum
2.00
tgi 52 mgu
USD 1.50
rdh 52 mgu
USD 0.00
Beta
1.07
Syer tertunggak
864.00K
Bilangan pekerja
23
Permodalan Pasaran
10.37K
Purata volum
182.00
Volum
2.00
tgi 52 mgu
USD 1.50
rdh 52 mgu
USD 0.00
Beta
1.07
Syer tertunggak
864.00K
Bilangan pekerja
23
Cerita berita
Daripada sumber web dan rakan kongsi berita
Moneycontrol.com
·
35 minit lalu
'AI is all that matters': How 42 artificial intelligence stocks drive 67% of S&P 500 gains since 2024
Finimize
·
33 minit lalu
PM Capital Blamed A Narrow US Rally For Its September Dip
BeInCrypto
·
1 jam lalu
A Few Stocks Carry the S&P 500: 41% of Stocks Trade 30% Below Highs
Barchart.com
·
6 jam lalu
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profil
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz winner of the 2012 Nobel Prize in Chemistry and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Trevena's expertise lies in engineering "biased ligands" that activate only the beneficial signaling pathways downstream of a GPCR to unlock new biology and avoid drug adverse effects. Trevena's pipeline currently includes a clinical stage mu-opioid biased ligand for post-operative pain, and discovery-stage programs for chronic pain, migraine, and Parkinson's disease. Wikipedia
Perihal Trevena Inc